Distant metastasis (DM) from head and neck cancers (HNC) portends a poor patient prognosis.
Despite its important biological role, little is known about the cells which seed these DM. …

Advances in immunotherapy have led to durable and long‐term benefits in a subset of
patients across a number of solid tumor types. Understanding of the subsets of patients that …

The discovery of immune checkpoint proteins such as PD-1/PDL-1 and CTLA-4 represents
a significant breakthrough in the field of cancer immunotherapy. Therefore, humanized …

Circulating tumor cells (CTCs) carry a wealth of information on primary and metastatic
tumors critical for precise cancer detection, monitoring, and treatment. Numerous microfluidic …

Gliomas are the most common tumours of the central nervous system and the most aggressive
form is glioblastoma (GBM). Despite advances in treatment, patient survival remains low. …

Objectives Thrombotic and microvascular complications are frequently seen in deceased
COVID‐19 patients. However, whether this is caused by direct viral infection of the endothelium …

Tumor biopsy is the gold standard for the assessment of clinical biomarkers for treatment.
However, tumors change dynamically in response to therapy, and there remains a need for a …

Coronavirus disease 2019 (COVID-19) has resulted in a global pandemic, challenging both
the medical and scientific community for the development of novel vaccines and a greater …

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has caused a global pandemic. The virus primarily affects the …

Lung cancer affects over 1. 8 million people worldwide and is the leading cause of cancer
related mortality globally. Currently, diagnosis of lung cancer involves a combination of …